Literature DB >> 31053964

[Ophthalmology 2019-where do we stand? : An analysis of the treatment situation in Germany].

Alexander K Schuster1, Christian Wolfram2, Norbert Pfeiffer3, Robert P Finger4.   

Abstract

The needs-based provision of medical services to the population represents a challenge for ophthalmology, not least as eye diseases become more frequent with age. Age-related macular degeneration, glaucoma, diabetic retinopathy and cataract occur particularly often. So far only few current population-based data have been available in Germany; however, this is currently changing with several ongoing population-based cohort studies, such as the Gutenberg Health Study, the National Cohort and the Rhineland Study. Preliminary data from the Gutenberg Health Study show that the expected increase in the prevalence of eye diseases with ageing has occurred and the development is comparable with international data from industrial countries. Over the last 15 years age-related eye diseases have increased by 15-34% due to demographic changes. The number of ophthalmologists increased during this period by 19%; however, as an ever increasing proportion do not work full time, the treatment time in ophthalmology only increased by 1%. Particularly in the working relationship of private practice employees, more ophthalmologists are now working than 15 years ago, the majority in part-time employment, whereas the number of self-employed ophthalmologists has declined. For ophthalmological care planning it is important to consider not only the age-related increase in patients but also the changes in treatment capacity, which cannot be solely derived from the absolute number of actively involved ophthalmologists.

Entities:  

Keywords:  Epidemiology; Health services research; Needs-based treatment; Prevalence; Utilization

Mesh:

Year:  2019        PMID: 31053964     DOI: 10.1007/s00347-019-0894-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  26 in total

1.  Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study.

Authors:  Christina A Korb; Ulrike B Kottler; Christian Wolfram; René Hoehn; Andreas Schulz; Isabella Zwiener; Philipp S Wild; Norbert Pfeiffer; Alireza Mirshahi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-25       Impact factor: 3.117

2.  [Prevalence and temporal trend of known diabetes mellitus: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  C Heidemann; Y Du; I Schubert; W Rathmann; C Scheidt-Nave
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

3.  [Utilization of outpatient and inpatient health services in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  P Rattay; H Butschalowsky; A Rommel; F Prütz; S Jordan; E Nowossadeck; O Domanska; P Kamtsiuris
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

4.  Blindness and visual impairment in Germany: a slight fall in prevalence.

Authors:  Robert P Finger; Bernd Bertram; Christian Wolfram; Frank G Holz
Journal:  Dtsch Arztebl Int       Date:  2012-07-09       Impact factor: 5.594

5.  Prevalence of refractive errors in the European adult population: the Gutenberg Health Study (GHS).

Authors:  Christian Wolfram; René Höhn; Ulrike Kottler; Philipp Wild; Maria Blettner; Jens Bühren; Norbert Pfeiffer; Alireza Mirshahi
Journal:  Br J Ophthalmol       Date:  2014-07       Impact factor: 4.638

Review 6.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.

Authors:  Wan Ling Wong; Xinyi Su; Xiang Li; Chui Ming G Cheung; Ronald Klein; Ching-Yu Cheng; Tien Yin Wong
Journal:  Lancet Glob Health       Date:  2014-01-03       Impact factor: 26.763

7.  Myopia and level of education: results from the Gutenberg Health Study.

Authors:  Alireza Mirshahi; Katharina A Ponto; René Hoehn; Isabella Zwiener; Tanja Zeller; Karl Lackner; Manfred E Beutel; Norbert Pfeiffer
Journal:  Ophthalmology       Date:  2014-06-16       Impact factor: 12.079

Review 8.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

Authors:  Yih-Chung Tham; Xiang Li; Tien Y Wong; Harry A Quigley; Tin Aung; Ching-Yu Cheng
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

9.  The ophthalmic branch of the Gutenberg Health Study: study design, cohort profile and self-reported diseases.

Authors:  René Höhn; Ulrike Kottler; Tunde Peto; Maria Blettner; Thomas Münzel; Stefan Blankenberg; Karl J Lackner; Manfred Beutel; Philipp S Wild; Norbert Pfeiffer
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

10.  Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study.

Authors:  Philipp Raum; Julia Lamparter; Katharina A Ponto; Tunde Peto; René Hoehn; Andreas Schulz; Astrid Schneider; Philipp S Wild; Norbert Pfeiffer; Alireza Mirshahi
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

View more
  3 in total

Review 1.  The Diagnosis and Treatment of Age-Related Macular Degeneration.

Authors:  Andreas Stahl
Journal:  Dtsch Arztebl Int       Date:  2020-07-20       Impact factor: 5.594

Review 2.  [Glaucoma surgery today].

Authors:  Esther M Hoffmann; Fritz Hengerer; Karsten Klabe; Marc Schargus; Hagen Thieme; Bogomil Voykov
Journal:  Ophthalmologe       Date:  2021-03       Impact factor: 1.059

3.  Impact of the COVID-19 pandemic's first wave on the care and treatment situation of intravitreal injections in a German metropolitan region.

Authors:  Birthe Stemplewitz; Joel Luethy; Ulrich Schaudig; Marc Schargus; Mau-Thek Eddy; Martin Spitzer; Ulrike Brocks; Julie Kieckhoefel; Christa Schneemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-10       Impact factor: 3.535

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.